Archives

Center for Food Safety and Applied Nutrition sends FDA warning letter to CBD manufacturer of products for adults and kids – for adulteration/misbranding FD&C Act violations.

Cosmetics are regulated by the Food, Drug, and Cosmetic Act. FDA’s primary focus on whether the cosmetics have been adulterated or misbranded.

Healthcare makers, distributors, and sellers must comply with FDA rules and warning letters for their cannabis, hemp, and THC products including foods, OTC drugs, cosmetics, and dietary supplements

The FDA examines whether medical devices comply with the regulations of the Food, Drug, and Cosmetic Act. Two of the most common violations medical device companies are charged are adulteration [...]

The FDA issues warning letters for numerous products including dietary supplements. FDA violations include findings that the supplement is a new drug, product adulteration, misbranding, and [...]

Federal Drug Administration continues to send warning letters to companies that boast products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.

The Farm Bill of 2018 legalized CBD products that are hemp based for certain pharmaceutical uses. Food and dietary supplement possibilities may follow. Many different federal and state laws and [...]